BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 32145537)

  • 61. Five microRNAs in plasma as novel biomarkers for screening of early-stage non-small cell lung cancer.
    Geng Q; Fan T; Zhang B; Wang W; Xu Y; Hu H
    Respir Res; 2014 Nov; 15(1):149. PubMed ID: 25421010
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer.
    Jiang YM; Yu DL; Hou GX; Jiang JL; Zhou Q; Xu XF
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31296790
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Epithelial-specific methylation marker: a potential plasma biomarker in advanced non-small cell lung cancer.
    Vinayanuwattikun C; Sriuranpong V; Tanasanvimon S; Chantranuwat P; Mutirangura A
    J Thorac Oncol; 2011 Nov; 6(11):1818-25. PubMed ID: 21964525
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Circulating U2 small nuclear RNA fragments as a diagnostic and prognostic biomarker in lung cancer patients.
    Köhler J; Schuler M; Gauler TC; Nöpel-Dünnebacke S; Ahrens M; Hoffmann AC; Kasper S; Nensa F; Gomez B; Hahnemann M; Breitenbuecher F; Cheufou D; Özkan F; Darwiche K; Hoiczyk M; Reis H; Welter S; Eberhardt WE; Eisenacher M; Teschler H; Stamatis G; Schmiegel W; Hahn SA; Baraniskin A
    J Cancer Res Clin Oncol; 2016 Apr; 142(4):795-805. PubMed ID: 26687686
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Tumor-derived exosomal lncRNA GAS5 as a biomarker for early-stage non-small-cell lung cancer diagnosis.
    Li C; Lv Y; Shao C; Chen C; Zhang T; Wei Y; Fan H; Lv T; Liu H; Song Y
    J Cell Physiol; 2019 Nov; 234(11):20721-20727. PubMed ID: 31032916
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Metabolite Profiles of the Serum of Patients with Non-Small Cell Carcinoma.
    Mazzone PJ; Wang XF; Beukemann M; Zhang Q; Seeley M; Mohney R; Holt T; Pappan KL
    J Thorac Oncol; 2016 Jan; 11(1):72-8. PubMed ID: 26762741
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Prediction of biomarkers of therapeutic effects of patients with lung adenocarcinoma treated with gefitinib based on progression-free-survival by metabolomic fingerprinting.
    Zhuang J; Tang X; Du Z; Yang M; Zhou Y
    Talanta; 2016 Nov; 160():636-644. PubMed ID: 27591660
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
    Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
    Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Detection and identification of potential biomarkers of non-small cell lung cancer.
    Yang Y; Zhao S; Fan Y; Zhao F; Liu Q; Hu W; Liu D; Fan K; Wang J; Wang J
    Technol Cancer Res Treat; 2009 Dec; 8(6):455-66. PubMed ID: 19925029
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Investigation of serum miR-411 as a diagnosis and prognosis biomarker for non-small cell lung cancer.
    Wang SY; Li Y; Jiang YS; Li RZ
    Eur Rev Med Pharmacol Sci; 2017 Sep; 21(18):4092-4097. PubMed ID: 29028091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Proteomics analysis of human serum of patients with non-small-cell lung cancer reveals proteins as diagnostic biomarker candidates.
    Boccellino M; Pinto F; Ieluzzi V; Giovane A; Quagliuolo L; Fariello C; Coppola M; Carlucci A; Santini M; Ferati K; Bexheti-Ferati A; Giordano A; Di Domenico M
    J Cell Physiol; 2019 Dec; 234(12):23798-23806. PubMed ID: 31180588
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Circulating long noncoding RNA GAS5 is a novel biomarker for the diagnosis of nonsmall cell lung cancer.
    Liang W; Lv T; Shi X; Liu H; Zhu Q; Zeng J; Yang W; Yin J; Song Y
    Medicine (Baltimore); 2016 Sep; 95(37):e4608. PubMed ID: 27631209
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A multi-analyte serum test for the detection of non-small cell lung cancer.
    Farlow EC; Vercillo MS; Coon JS; Basu S; Kim AW; Faber LP; Warren WH; Bonomi P; Liptay MJ; Borgia JA
    Br J Cancer; 2010 Oct; 103(8):1221-8. PubMed ID: 20859284
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Combined identification of long non-coding RNA XIST and HIF1A-AS1 in serum as an effective screening for non-small cell lung cancer.
    Tantai J; Hu D; Yang Y; Geng J
    Int J Clin Exp Pathol; 2015; 8(7):7887-95. PubMed ID: 26339353
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Classification of Epidermal Growth Factor Receptor Gene Mutation Status Using Serum Proteomic Profiling Predicts Tumor Response in Patients with Stage IIIB or IV Non-Small-Cell Lung Cancer.
    Yang L; Tang C; Xu B; Wang W; Li J; Li X; Qin H; Gao H; He K; Song S; Liu X
    PLoS One; 2015; 10(6):e0128970. PubMed ID: 26047516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Simultaneous quantification of serum monounsaturated and polyunsaturated phosphatidylcholines as potential biomarkers for diagnosing non-small cell lung cancer.
    Chen Y; Ma Z; Zhong J; Li L; Min L; Xu L; Li H; Zhang J; Wu W; Dai L
    Sci Rep; 2018 May; 8(1):7137. PubMed ID: 29740076
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Serum untargeted metabolomics reveal metabolic alteration of non-small cell lung cancer and refine disease detection.
    Li J; Liu K; Ji Z; Wang Y; Yin T; Long T; Shen Y; Cheng L
    Cancer Sci; 2023 Feb; 114(2):680-689. PubMed ID: 36310111
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Application of serum surface-enhanced laser desorption/ionization proteomic patterns in distinguishing non-small cell lung cancer patients from healthy people].
    Yang SY; Xiao XY; Zhang WG; Sun XZ; Zhang LJ; Zhang W; Zhou B; Yang DC; He DC
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jan; 29(1):31-4. PubMed ID: 16638298
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Discovery of lung cancer biomarkers by profiling the plasma proteome with monoclonal antibody libraries.
    Guergova-Kuras M; Kurucz I; Hempel W; Tardieu N; Kádas J; Malderez-Bloes C; Jullien A; Kieffer Y; Hincapie M; Guttman A; Csánky E; Dezso B; Karger BL; Takács L
    Mol Cell Proteomics; 2011 Dec; 10(12):M111.010298. PubMed ID: 21947365
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Serum Cripto-1 is a novel biomarker for non-small cell lung cancer diagnosis and prognosis.
    Xu CH; Wang Y; Qian LH; Yu LK; Zhang XW; Wang QB
    Clin Respir J; 2017 Nov; 11(6):765-771. PubMed ID: 26605871
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.